ARTICLE | Clinical News
Lysodase PEG-glucocerebrosidase: Began Phase I trial
January 16, 1995 8:00 AM UTC
Enzon Inc. (ENZN), Piscataway, N.J. Product: Lysodase PEG- glucocerebrosidase Indication: Gaucher's disease, to correct the genetic lack of glucocerebrosidase Status: Began Phase I trial ...